Activity, efficacy, and safety of nab-paclitaxel (Nab-P) and gemcitabine (G) in heaviliy pretreated advanced pancreatic cancer (APDAC) patients (pts): A multicenter retrospective analysis.
Antonio Febbraro
No relevant relationships to disclose
Alberto Zaniboni
No relevant relationships to disclose
Vittorina Zagonel
No relevant relationships to disclose
Francesco Di Costanzo
No relevant relationships to disclose
Luigi Maiorino
No relevant relationships to disclose
Paola Bertocchi
No relevant relationships to disclose
Francesca Bergamo
No relevant relationships to disclose
Elisa Giommoni
No relevant relationships to disclose
Guido Giordano
No relevant relationships to disclose